Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases
Ewa Pronicka(Children's Memorial Health Institute), Mieczysław Litwin(Children's Memorial Health Institute), Paulina Halat(Children's Memorial Health Institute), Janusz Książyk(Children's Memorial Health Institute), Elżbieta Ciara(Children's Memorial Health Institute), Agnieszka Janiec(Children's Memorial Health Institute), Dariusz Rokicki(Children's Memorial Health Institute), Paweł Płudowski(Children's Memorial Health Institute), Ewa Wojciechowska(Children's Memorial Health Institute), E Rowińska(Children's Memorial Health Institute), Martin Konrad(University Hospital Münster), Agnieszka Jacoszek(Medical University of Warsaw), Marek Wójcik(Children's Memorial Health Institute), Aldona Wierzbicka(Children's Memorial Health Institute), Karl P. Schlingmann(University Hospital Münster)
Cited by 94
Related Papers
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents
|Journal of Hypertension|2016|1.4k
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure
|Nature Genetics|2001|538
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361
Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex
|Journal of Clinical Investigation|2008|333